Figure 1.
Hematologic response analysis by subject number over time. (A) The number of cycles of protocol treatment is shown on the x-axis and the subject number is shown on the y-axis; hematologic response analysis is shown on individual subject bars at the end. (B) Hematologic dFLC response after 1 dose of daratumumab in relapsed AL amyloidosis.